Show simple item record

dc.contributor.authorOgungbenro, K
dc.contributor.authorPatel, Alkesh
dc.contributor.authorDuncombe, Robert
dc.contributor.authorClark, James
dc.contributor.authorLorigan, Paul C
dc.date.accessioned2017-04-23T20:03:06Z
dc.date.available2017-04-23T20:03:06Z
dc.date.issued2016-10-01
dc.identifier.citationA rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation. 2016, 27(suppl_6):1082P Annals of Oncologyen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdw378.36
dc.identifier.urihttp://hdl.handle.net/10541/620272
dc.language.isoenen
dc.relation.urlhttps://academic.oup.com/annonc/article/2799877/Aen
dc.rightsArchived with thanks to Annals of Oncologyen
dc.titleA rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentCentre for Applied Pharmacokinetic Research, The University of Manchester, Manchester,en
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record